| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.55 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |